Furthermore, after pretreating hNPCs with IL-1β to mimic the inflammatory milieu of IDD, MSC-derived secretomes showed to effectively blunt the catabolic effects of in vitro inflammation (Le Maitre et al., 2005). Here, IL1B is linked to intervertebral disk degenerative disorder.